These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32988380)

  • 21. CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
    Navratilova E; Rau J; Oyarzo J; Tien J; Mackenzie K; Stratton J; Remeniuk B; Schwedt T; Anderson T; Dodick D; Porreca F
    Cephalalgia; 2019 Dec; 39(14):1762-1775. PubMed ID: 31550910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Headache determines quality of life in idiopathic intracranial hypertension.
    Mulla Y; Markey KA; Woolley RL; Patel S; Mollan SP; Sinclair AJ
    J Headache Pain; 2015; 16():521. PubMed ID: 25982204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic fatigue syndrome and idiopathic intracranial hypertension: Different manifestations of the same disorder of intracranial pressure?
    Higgins JNP; Pickard JD; Lever AML
    Med Hypotheses; 2017 Aug; 105():6-9. PubMed ID: 28735654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analysis of allodynia in patients with idiopathic intracranial hypertension.
    Ekizoglu E; Baykan B; Orhan EK; Ertas M
    Cephalalgia; 2012 Oct; 32(14):1049-58. PubMed ID: 22875880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
    Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
    JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension.
    Westgate CSJ; Israelsen IME; Jensen RH; Eftekhari S
    J Headache Pain; 2021 Oct; 22(1):123. PubMed ID: 34629054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
    Khan S; Olesen A; Ashina M
    Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric Idiopathic Intracranial Hypertension (IIH)-A Review.
    Malem A; Sheth T; Muthusamy B
    Life (Basel); 2021 Jun; 11(7):. PubMed ID: 34209834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CGRP, Amylin, Immunology, and Headache Medicine.
    Taylor FR
    Headache; 2019 Jan; 59(1):131-150. PubMed ID: 30390312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of new-onset migraine in patients with idiopathic intracranial hypertension in comparison to the general population.
    Togha M; Shirbache K; Rahmanzadeh R; Ghorbani Z; Yari Z; Refaeian F; Behbahani S; Panahi P
    Iran J Neurol; 2018 Oct; 17(4):161-166. PubMed ID: 31210900
    [No Abstract]   [Full Text] [Related]  

  • 31. Erenumab in highly therapy-refractory migraine patients: First German real-world evidence.
    Scheffler A; Messel O; Wurthmann S; Nsaka M; Kleinschnitz C; Glas M; Naegel S; Holle D
    J Headache Pain; 2020 Jul; 21(1):84. PubMed ID: 32620151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema.
    Mollan SP; Chong YJ; Grech O; Sinclair AJ; Wakerley BR
    Life (Basel); 2021 May; 11(6):. PubMed ID: 34073844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Headaches in Idiopathic Intracranial Hypertension.
    Friedman DI
    J Neuroophthalmol; 2019 Mar; 39(1):82-93. PubMed ID: 30762716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials.
    Khatkar P; Hubbard JC; Hill L; Sinclair AJ; Mollan SP
    Expert Opin Investig Drugs; 2023; 32(12):1123-1131. PubMed ID: 38006580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.
    Sacco S; Bendtsen L; Ashina M; Reuter U; Terwindt G; Mitsikostas DD; Martelletti P
    J Headache Pain; 2019 Jan; 20(1):6. PubMed ID: 30651064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
    Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
    Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic intracranial hypertension headache.
    Digre KB
    Curr Pain Headache Rep; 2002 Jun; 6(3):217-25. PubMed ID: 12003693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
    Yuan H; Spare NM; Silberstein SD
    Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cluster-like headache secondary to idiopathic intracranial hypertension.
    Volcy M; Tepper SJ
    Cephalalgia; 2006 Jul; 26(7):883-6. PubMed ID: 16776707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Use of Endoscopic Third Ventriculostomy as Treatment for Idiopathic Intracranial Hypertension: Case Report and a Review of Previously Reported Cases.
    Trenchfield D; Di L; Shah A; Desai D; Gudoor P; Eichberg DG; Luther EM; Komotar RJ
    World Neurosurg; 2020 Sep; 141():373-376. PubMed ID: 32634635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.